Total Payments
$531.29
2018 Payments
$336.30
Companies
11
Transactions
29
Payment Breakdown by Category
Food & Beverage$531.29 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $531.29 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $92.84 | 4 | $0 (2018) |
| Celgene Corporation | $77.51 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $71.89 | 5 | $0 (2018) |
| Janssen Biotech, Inc. | $59.64 | 3 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $53.90 | 3 | $0 (2018) |
| Eisai Inc. | $39.65 | 2 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $33.85 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.11 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $30.71 | 2 | $0 (2018) |
| Amgen Inc. | $20.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $336.30 | 18 | E.R. Squibb & Sons, L.L.C. ($74.59) |
| 2017 | $194.99 | 11 | Celgene Corporation ($61.87) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $16.43 | General |
| 11/30/2018 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Oncology | ||||||
| 11/16/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Oncology | ||||||
| 11/09/2018 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Oncology | ||||||
| 11/02/2018 | Eisai Inc. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $22.22 | General |
| Category: Oncology | ||||||
| 10/12/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 09/21/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.93 | General |
| 09/14/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.89 | General |
| Category: Oncology | ||||||
| 08/17/2018 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Oncology | ||||||
| 07/27/2018 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 06/29/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
| 05/11/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $25.84 | General |
| Category: Oncology | ||||||
| 05/04/2018 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Oncology | ||||||
| 04/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2018 | Bayer HealthCare Pharmaceuticals Inc. | Nexavar (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Oncology | ||||||
| 03/07/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: Oncology | ||||||
| 02/02/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2018 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 12/08/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2017 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Oncology | ||||||
| 10/20/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Hematology / Oncology | ||||||
| 10/13/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $12.17 | General |
| 09/14/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Oncology | ||||||
| 09/08/2017 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Oncology | ||||||
| 07/21/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| Category: Oncology | ||||||
About Dr. Kenneth Heisler, MD
Dr. Kenneth Heisler, MD is a Surgery healthcare provider based in Falmouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427100460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Heisler, MD has received a total of $531.29 in payments from pharmaceutical and medical device companies, with $336.30 received in 2018. These payments were reported across 29 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($531.29).
Ad
Practice Information
- Specialty Surgery
- Location Falmouth, MA
- Active Since 01/18/2007
- Last Updated 06/02/2016
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1427100460
Products in Payments
- OPDIVO (Biological) $92.84
- Abraxane (Drug) $54.04
- Erleada (Drug) $40.55
- Halaven (Drug) $39.65
- Stivarga (Drug) $36.61
- Imbruvica (Drug) $33.85
- GILOTRIF (Drug) $32.11
- FASLODEX (Drug) $30.71
- KEYTRUDA (Biological) $28.36
- Revlimid (Drug) $23.47
- Neulasta (Biological) $20.53
- ZYTIGA (Drug) $19.09
- VERZENIO (Drug) $18.66
- Nexavar (Drug) $17.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Falmouth
Mr. Peter Hopewood, Md, MD
Surgery — Payments: $1,416
Surgery $1,416
Mr. Garry Brake, Md, MD
Surgery — Payments: $1,373
Surgery $1,373
Mr. Patrick Flynn, Md, MD
Surgery — Payments: $1,306
Surgery $1,306
Mr. Alan Cordts, M.d, M.D
Surgery — Payments: $54.27
Surgery $54.27
Terence Christle, M.d, M.D
Surgery
Surgery